Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PAUL M RIDKER

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1063478261
CMS profile
184622
Location
BOSTON, MA

General Payments · PY2018–2024

$549,835.21

  • Reported across 271 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$91,997.10

48 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $72,663.25 19
Travel and Lodging $18,511.70 22
Food and Beverage $822.15 7

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
AGEPHA Pharma FZ LLC $41,389.41 16
Acerta Pharma LLC $10,471.50 1
Novo Nordisk AS $9,982.45 6
Eli Lilly and Company $8,597.93 11
CSL Behring $6,635.00 3
Merck Sharp & Dohme Corporation $4,905.00 4
PFIZER INC. $4,368.00 3
Novo Nordisk AS $3,293.75 1
Esperion Therapeutics, Inc. $2,240.00 2
Amgen Inc. $114.06 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $87,274.75 63
PY2019 $113,759.77 70
PY2020 $41,379.50 17
PY2021 $48,864.00 21
PY2022 $53,289.06 21
PY2023 $113,271.03 31
PY2024 $91,997.10 48

Payment records · PY2024 (48)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AGEPHA Pharma FZ LLC $25,000.00 03/27/2024 Consulting Fee Undisputed 01/23/2026 1111016346 CMS
AGEPHA Pharma FZ LLC $980.46 03/27/2024 Travel and Lodging Undisputed 01/23/2026 1111016350 CMS
AGEPHA Pharma FZ LLC $980.60 03/27/2024 Travel and Lodging Undisputed 01/23/2026 1111016352 CMS
AGEPHA Pharma FZ LLC $380.20 03/27/2024 Travel and Lodging Undisputed 01/23/2026 1111016354 CMS
AGEPHA Pharma FZ LLC $420.42 03/27/2024 Travel and Lodging Undisputed 01/23/2026 1111016360 CMS
AGEPHA Pharma FZ LLC $1,106.34 03/27/2024 Travel and Lodging Undisputed 01/23/2026 1111016362 CMS
AGEPHA Pharma FZ LLC $720.36 09/04/2024 Travel and Lodging Undisputed 01/23/2026 1111016358 CMS
AGEPHA Pharma FZ LLC $1,108.60 09/04/2024 Travel and Lodging Undisputed 01/23/2026 1111016364 CMS
AGEPHA Pharma FZ LLC $944.08 09/04/2024 Travel and Lodging Undisputed 01/23/2026 1111016366 CMS
AGEPHA Pharma FZ LLC $108.81 09/04/2024 Travel and Lodging Undisputed 01/23/2026 1111016370 CMS
AGEPHA Pharma FZ LLC $360.55 09/04/2024 Travel and Lodging Undisputed 01/23/2026 1111016372 CMS
AGEPHA Pharma FZ LLC $422.08 09/04/2024 Travel and Lodging Undisputed 01/23/2026 1111016374 CMS
AGEPHA Pharma FZ LLC $3,408.00 09/04/2024 Travel and Lodging Undisputed 01/23/2026 1111016380 CMS
AGEPHA Pharma FZ LLC $846.20 09/04/2024 Travel and Lodging Undisputed 01/23/2026 1111016382 CMS
AGEPHA Pharma FZ LLC $336.00 09/04/2024 Travel and Lodging Undisputed 01/23/2026 1111016384 CMS
AGEPHA Pharma FZ LLC $4,266.71 09/04/2024 Travel and Lodging Undisputed 01/23/2026 1111016386 CMS
Amgen Inc. $114.06 04/25/2024 Food and Beverage Undisputed 01/23/2026 1116057419 CMS
AstraZeneca Pharmaceuticals LP $10,471.50 12/09/2024 Consulting Fee Undisputed 01/23/2026 1104365501 CMS
CSL Behring $1,635.00 01/12/2024 Consulting Fee Undisputed 01/23/2026 1134637313 CMS
CSL Behring $2,000.00 02/09/2024 Consulting Fee Undisputed 01/23/2026 1134637197 CMS
CSL Behring $3,000.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 1134637315 CMS
Eli Lilly and Company $340.68 03/19/2024 Travel and Lodging Undisputed 01/23/2026 1135286061 CMS
Eli Lilly and Company $34.95 03/19/2024 Food and Beverage Undisputed 01/23/2026 1135312913 CMS
Eli Lilly and Company $4,800.00 03/27/2024 Consulting Fee Undisputed 01/23/2026 1135286057 CMS
Eli Lilly and Company $26.00 04/19/2024 Travel and Lodging Undisputed 01/23/2026 1135188519 CMS
Eli Lilly and Company $45.74 04/19/2024 Food and Beverage Undisputed 01/23/2026 1135312917 CMS
Eli Lilly and Company $20.06 04/19/2024 Food and Beverage Undisputed 01/23/2026 1135312921 CMS
Eli Lilly and Company $9.00 05/01/2024 Food and Beverage Undisputed 01/23/2026 1135270873 CMS
Eli Lilly and Company $41.00 05/01/2024 Travel and Lodging Undisputed 01/23/2026 1135277327 CMS
Eli Lilly and Company $8.34 05/06/2024 Food and Beverage Undisputed 01/23/2026 1135270881 CMS
Eli Lilly and Company $3,200.00 05/09/2024 Consulting Fee Undisputed 01/23/2026 1135270876 CMS
Eli Lilly and Company $72.16 05/14/2024 Travel and Lodging Undisputed 01/23/2026 1135188521 CMS
Esperion Therapeutics, Inc. $1,120.00 01/12/2024 Consulting Fee Undisputed 01/23/2026 1129452468 CMS
Esperion Therapeutics, Inc. $1,120.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1129452470 CMS
Merck Sharp & Dohme LLC $545.00 05/20/2024 Consulting Fee Undisputed 01/23/2026 1141790946 CMS
Merck Sharp & Dohme LLC $545.00 05/27/2024 Consulting Fee Undisputed 01/23/2026 1141790950 CMS
Merck Sharp & Dohme LLC $545.00 09/09/2024 Consulting Fee Undisputed 01/23/2026 1141790948 CMS
Merck Sharp & Dohme LLC $3,270.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1141793368 CMS
Novo Nordisk AS $5,425.00 04/29/2024 Consulting Fee Undisputed 01/23/2026 1096552755 CMS
Novo Nordisk AS $590.00 04/29/2024 Food and Beverage Undisputed 01/23/2026 1096553043 CMS
Novo Nordisk AS $294.16 04/29/2024 Travel and Lodging Undisputed 01/23/2026 1096553263 CMS
Novo Nordisk AS $570.58 04/29/2024 Travel and Lodging Undisputed 01/23/2026 1096553269 CMS
Novo Nordisk AS $777.71 04/29/2024 Travel and Lodging Undisputed 01/23/2026 1096553443 CMS
Novo Nordisk AS $2,325.00 08/29/2024 Consulting Fee Undisputed 01/23/2026 1096553151 CMS
Novo Nordisk Inc $3,293.75 11/16/2024 Consulting Fee Undisputed 01/23/2026 1096742584 CMS
PFIZER INC. $3,600.00 04/15/2024 Consulting Fee Undisputed 01/23/2026 1130904411 CMS
PFIZER INC. $268.00 07/29/2024 Consulting Fee Undisputed 01/23/2026 1130925393 CMS
PFIZER INC. $500.00 08/12/2024 Consulting Fee Undisputed 01/23/2026 1130931639 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.